Semaglutide and Testosterone Levels: A Clinical Perspective

Written by Adam Maggio | Medically reviewed by Dr. Mitchell Ross, MD, ABAARM

Semaglutide often improves testosterone levels in men, particularly those with obesity, primarily by reducing fat mass and aromatase activity. While not a direct testosterone replacement, it can synergize with TRT for comprehensive metabolic and hormonal well-being.

Many men considering semaglutide for weight management or diabetes control often inquire about its impact on testosterone levels. The prevailing clinical evidence suggests that semaglutide does not directly suppress testosterone; in fact, it frequently leads to an improvement in testosterone levels, particularly in men with obesity or type 2 diabetes.

The primary mechanism behind semaglutide"s positive influence on testosterone is its profound effect on weight loss and metabolic health. Obesity is a well-established risk factor for low testosterone (hypogonadism) in men. Adipose tissue, particularly visceral fat, contains aromatase, an enzyme that converts testosterone into estrogen. This conversion reduces circulating testosterone and can exacerbate symptoms of low T. As semaglutide facilitates significant and sustained weight loss, it reduces adipose tissue, thereby decreasing aromatase activity and allowing testosterone levels to rise. Studies, such as those highlighted by Healio (2025) and Healthline (2025), consistently show that men using GLP-1 receptor agonists like semaglutide experience a rise in free and total testosterone after initiating treatment. This is a crucial point, as it indicates a restoration of the body"s natural hormonal balance rather than a direct pharmacological intervention on testosterone production.

Beyond weight loss, there"s emerging research suggesting more direct effects of GLP-1 receptor agonists on male reproductive health. While not as extensively studied as the weight loss mechanism, some investigations indicate that GLP-1RAs may have favorable effects on gonadotropin secretion, which in turn can influence testosterone production. For instance, a study by Varnum et al. (2023) and Deameh et al. (2026) pointed towards GLP-1RAs potentially enhancing sperm metabolism, motility, and insulin secretion in vitro, and improving testosterone levels in men with metabolic issues. Preclinical studies, as noted by Weill Cornell (2025), even suggest GLP-1RAs can enhance spermatogenesis and hormone profiles in obese/diabetic rodent models via specific cellular pathways, such as the cAMP/PKA pathway. These findings, while preliminary, open avenues for understanding a broader role of GLP-1 in male endocrine function.

It"s important to understand the clinical nuance here. While semaglutide can lead to increased testosterone, it"s not a direct testosterone replacement therapy. Its action is more akin to restoring physiological balance by addressing underlying metabolic dysfunction. For men with clinically low testosterone, combining semaglutide with testosterone replacement therapy (TRT) can be a highly effective strategy. Hone Health (2025) suggests that this combination may help men with low testosterone lose fat while preserving muscle mass, offering a synergistic approach to improving body composition and hormonal health. A study presented at the Endocrine Abstracts (2025) even indicated that semaglutide was superior to TRT in improving body composition and comparably increased testosterone, alongside improved symptoms of androgen deficiency. This dual approach can be particularly beneficial for men struggling with both obesity and hypogonadism, where each condition exacerbates the other.

Patients should be aware that the improvements in testosterone are generally observed in men whose low levels are secondary to obesity or metabolic syndrome. For men with primary hypogonadism, where the testes themselves are not producing enough testosterone, semaglutide alone is unlikely to normalize levels, and TRT would still be the appropriate treatment. However, even in these cases, the metabolic benefits of semaglutide can significantly improve overall health and quality of life, potentially making TRT more effective or reducing its required dosage. It"s also worth noting that the timeline for testosterone improvement can vary; some men may see changes within a few months, while for others, it might take longer as weight loss progresses.

Regular monitoring of hormone levels is advisable for men undergoing semaglutide treatment, especially if they have pre-existing concerns about testosterone. This allows for personalized adjustments to treatment plans and ensures that any hormonal imbalances are addressed appropriately. Lifestyle factors, such as adequate sleep, stress management, and a balanced diet rich in micronutrients, also play a supportive role in optimizing testosterone production and overall endocrine health, complementing the effects of semaglutide. Unlike a quick fix, this integrated approach addresses the multifactorial nature of hormonal health.

For men on semaglutide, prioritizing weight loss through diet and exercise, coupled with the medication, often leads to a natural increase in testosterone levels. If you"re experiencing symptoms of low testosterone, discuss with your physician whether semaglutide, potentially in conjunction with TRT, is the right approach for you. The goal is not just weight loss, but comprehensive metabolic and hormonal well-being, leading to improved vitality and quality of life.